Prognostic Values of G-Protein Mutations in Metastatic Uveal Melanoma

被引:13
|
作者
Terai, Mizue [1 ]
Shimada, Ayako [2 ]
Chervoneva, Inna [2 ]
Hulse, Liam [1 ]
Danielson, Meggie [1 ]
Swensen, Jeff [3 ]
Orloff, Marlana [1 ]
Wedegaertner, Philip B. [4 ]
Benovic, Jeffrey L. [4 ]
Aplin, Andrew E. [5 ]
Sato, Takami [1 ]
机构
[1] Thomas Jefferson Univ, Sidney Kimmel Canc Ctr, Dept Med Oncol, Philadelphia, PA 19107 USA
[2] Thomas Jefferson Univ, Sidney Kimmel Canc Ctr, Dept Pharmacol & Expt Therapeut, Philadelphia, PA 19107 USA
[3] Caris Life Sci, Mol Genet, Phoenix, AZ 85040 USA
[4] Thomas Jefferson Univ, Sidney Kimmel Canc Ctr, Dept Biochem & Mol Biol, Philadelphia, PA 19107 USA
[5] Thomas Jefferson Univ, Sidney Kimmel Canc Ctr, Dept Canc Biol, Philadelphia, PA 19107 USA
关键词
uveal melanoma; metastasis; metastatic uveal melanoma; survival; GNA11; GNAQ; Q209P; Q209L; BAP1; SF3B1; ONCOGENIC MUTATIONS; GNAQ; SURVIVAL;
D O I
10.3390/cancers13225749
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Simple Summary: Uveal melanoma (UM) is the most common primary intraocular malignancy in adults. More than 90% of UMs harbor mutually exclusive activating mutations in G-proteins. The mutations are early events in UM development and considered to be driver mutations in carcinogenesis. Even after treatment of primary uveal melanoma, up to 50% of patients subsequently develop recurrence, predominantly in the liver. GNAQ mutations are not reported to be correlated to survival, while the mutations in GNA11 are reported more frequently in metastatic UM. We investigated the correlation of survival after development of metastasis (Met-to-Death) of metastatic uveal melanoma (MUM) patients with GNA11 and GNAQ mutations. We identified that MUM with mutation patterns of Q209P vs. Q209L in GNA11 and GNAQ might predict survival of MUM patients. Uveal melanoma is the most common primary ocular malignancy in adults, characterized by gene mutations in G protein subunit alpha q (GNAQ) and G protein subunit alpha 11 (GNA11). Although they are considered to be driver mutations, their role in MUM remains elusive. We investigated key somatic mutations ofMUM and their impact on patients' survival after development of systemic metastasis (Met-to-Death). Metastatic lesions from 87 MUM patients were analyzed by next generation sequencing (NGS). GNA11 (41/87) and GNAQ (39/87) mutations were most predominantly seen in MUM. Most GNA11 mutations were Q209L (36/41), whereas GNAQ mutations comprised Q209L (14/39) and Q209P (21/39). Epigenetic pathway mutations BAP1 (42/66), SF3B1 (11/66), FBXW7 (2/87), PBRM1 (1/66), and SETD2 (1/66) were found. No specimen had the EIF1AX mutation. Interestingly, Met-to-Death was longer in patients with GNAQ Q209P compared to GNAQ/GNA11 Q209L mutations, suggesting the difference in mutation type in GNAQ/GNA11 might determine the prognosis of MUM. Structural alterations of the GNAQ/GNA11 protein and their impact on survival of MUM patients should be further investigated.
引用
收藏
页数:14
相关论文
共 50 条
  • [1] Mutations as prognostic factor in uveal melanoma
    Kilic, E.
    ACTA OPHTHALMOLOGICA, 2018, 96 : 63 - 63
  • [2] Targeting primary and metastatic uveal melanoma with a G protein inhibitor
    Onken, Michael D.
    Makepeace, Carol M.
    Kaltenbronn, Kevin M.
    Choi, Joelle
    Hernandez-Aya, Leonel
    Weilbaecher, Katherine N.
    Piggott, Kisha D.
    Rao, P. Kumar
    Yuede, Carla M.
    Dixon, Alethia J.
    Osei-Owusu, Patrick
    Cooper, John A.
    Blumer, Kendall J.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2021, 296
  • [3] Metastatic Uveal Melanoma: a Prognostic Model and Nomogram
    Parrozzani, Raffaele
    Valpione, Sara
    Chiarion-Sileni, Vanna
    Kotsafti, Olympia
    Midena, Edoardo
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2014, 55 (13)
  • [4] A prognostic model and staging for metastatic uveal melanoma
    Eskelin, S
    Pyrhönen, S
    Hahka-Kemppinen, M
    Tuomaala, S
    Kivelä, T
    CANCER, 2003, 97 (02) : 465 - 475
  • [5] Multivariate prognostic factors in metastatic uveal melanoma (UM)
    Deeb, Ayham
    Karim, Nagla Abdel
    Leming, Philip D.
    Bhatt, Ananta
    Namad, Tariq
    Xie, Changchun
    Hunt, Jillian
    Correa, Zelia
    Augsburger, James
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [6] The Prognostic Values of PARP-1 Expression in Uveal Melanoma
    Gajdzis, Malgorzata
    Theocharis, Stamatios
    Klijanienko, Jerzy
    Cassoux, Nathalie
    Gardrat, Sophie
    Donizy, Piotr
    Kaczmarek, Radoslaw
    Gajdzis, Pawel
    CELLS, 2021, 10 (02) : 1 - 12
  • [7] Prognostic Relevance of Circulating Tumor Cells in Metastatic Uveal Melanoma
    Schuster, R.
    Bechrakis, N. E.
    Stroux, A.
    Busse, A.
    Schmittel, A.
    Thiel, E.
    Foerster, M. H.
    Keilholz, U.
    ONCOLOGY, 2011, 80 (1-2) : 57 - 62
  • [8] Development and External Validation of a Prognostic Nomogram for Metastatic Uveal Melanoma
    Valpione, Sara
    Moser, Justin C.
    Parrozzani, Raffaele
    Bazzi, Marco
    Mansfield, Aaron S.
    Mocellin, Simone
    Pigozzo, Jacopo
    Midena, Edoardo
    Markovic, Svetomir N.
    Aliberti, Camillo
    Campana, Luca G.
    Chiarion-Sileni, Vanna
    PLOS ONE, 2015, 10 (03):
  • [9] Metastatic Uveal Melanoma
    Sacks, Chana A.
    NEW ENGLAND JOURNAL OF MEDICINE, 2019, 380 (19): : 1853 - 1853
  • [10] Protein kinase signaling pathways in metastatic uveal melanoma
    Caminal, Jose M. M.
    Cabre, Eduard
    Vinyals, Antonia
    Goma, Montse
    Piulats, Josep M.
    Varela, Mar
    Lorenzo, Daniel
    Subira, Olaia
    Jose Paules, Maria
    Arias, Lluis
    Rubio, Marc
    Cobos, Estefania
    Garcia-Bru, Pere
    Medeiros, Bruno
    Padron, Noel
    Fabra, Angels
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2017, 58 (08)